Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases by Mitchell, J, Camacho, N, Shea, P, Stopsack, KH, Joseph, V, Burren, OS, Dhindsa, RS, Nag, A, Berchuck, JE, O’Neill, A, Abbasi, A, Zoghbi, AW, Alegre-Díaz, J, Kuri-Morales, P, Berumen, J, Tapia-Conyer, R, Emberson, J, Torres, JM, Collins, R, Wang, Q, Goldstein, D, Matakidou, A, Haefliger, C, Anderson-Dring, L